Crossword Solver > found answer > INCRETIO

Welcome to Anagrammer Crossword Genius! Keep reading below to see if incretio is an answer to any crossword puzzle or word game (Scrabble, Words With Friends etc). Scroll down to see all the info we have compiled on incretio.

CROSSWORD
ANSWER

incretio

Searching in Crosswords ...

The answer INCRETIO has 0 possible clue(s) in existing crosswords.

Searching in Word Games ...

The word INCRETIO is NOT valid in any word game. (Sorry, you cannot play INCRETIO in Scrabble, Words With Friends etc)

There are 8 letters in INCRETIO ( C³E¹I¹N¹O¹R¹T¹ )

To search all scrabble anagrams of INCRETIO, to go: INCRETIO?

Rearrange the letters in INCRETIO and see some winning combinations

5 letters out of INCRETIO

4 letters out of INCRETIO

3 letters out of INCRETIO

CON COR COT EON ERN ICE ION IRE NET NIT NOR NOT ONE ORC ORE ORT REC REI RET RIN ROC ROE ROT TEN TIC TIE TIN TOE TON TOR

2 letters out of INCRETIO

EN ER ET IN IT NE NO OE OI ON OR RE TI TO

Searching in Dictionaries ...

Definitions of incretio in various dictionaries:

No definitions found

Word Research / Anagrams and more ...

Keep reading for additional results and analysis below.

Incretio might refer to
Incretins are a group of metabolic hormones that stimulate a decrease in blood glucose levels. Incretins are released after eating and augment the secretion of insulin released from pancreatic beta cells of the islets of Langerhans by a blood glucose-dependent mechanism. They also slow the rate of absorption of nutrients into the blood stream by reducing gastric emptying and may directly reduce food intake. In addition, they inhibit glucagon release from the alpha cells of the islets of Langerhans. The two main candidate molecules that fulfill criteria for an incretin are the intestinal peptides glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (also known as: glucose-dependent insulinotropic polypeptide or GIP). Both GLP-1 and GIP are rapidly inactivated by the enzyme dipeptidyl peptidase-4 (DPP-4); both GLP-1 and GIP are members of the glucagon peptide superfamily."Many factors stimulate insulin secretion, but the main one is blood glucose. Incretins, especially GIP and GLP-1 secreted, respectively, by K and L cells in the gut are also important" (Rang and Dale's Pharmacology (2015)). * GLP-1 (7-36) amide is not very useful for treatment of type 2 diabetes mellitus, since it must be administered by continuous subcutaneous infusion. Several long-lasting analogs having insulinotropic activity have been developed, and three, exenatide (Byetta) and liraglutide (Victoza), plus exenatide extended-release (Bydureon), have been approved for use in the U.S. The main disadvantage of these GLP-1 analogs is they must be administered by subcutaneous injection. * Another approach is to inhibit the enzyme that inactivates GLP-1 and GIP, DPP-4. Several DPP-4 inhibitors that can be taken orally as tablets have been developed. * Once weekly dosage of GLP-1 receptor agonists is also an approved modality in treating type 2 diabetes.*

Incretio might refer to

Incretins are a group of metabolic hormones that stimulate a decrease in blood glucose levels. Incretins are released after eating and augment the secretion of insulin released from pancreatic beta cells of the islets of Langerhans by a blood glucose-dependent mechanism. They also slow the rate of absorption of nutrients into the blood stream by reducing gastric emptying and may directly reduce food intake. In addition, they inhibit glucagon release from the alpha cells of the islets of Langerhans. The two main candidate molecules that fulfill criteria for an incretin are the intestinal peptides glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (also known as: glucose-dependent insulinotropic polypeptide or GIP). Both GLP-1 and GIP are rapidly inactivated by the enzyme dipeptidyl peptidase-4 (DPP-4); both GLP-1 and GIP are members of the glucagon peptide superfamily."Many factors stimulate insulin secretion, but the main one is blood glucose. Incretins, especially GIP and GLP-1 secreted, respectively, by K and L cells in the gut are also important" (Rang and Dale's Pharmacology (2015)).
* GLP-1 (7-36) amide is not very useful for treatment of type 2 diabetes mellitus, since it must be administered by continuous subcutaneous infusion. Several long-lasting analogs having insulinotropic activity have been developed, and three, exenatide (Byetta) and liraglutide (Victoza), plus exenatide extended-release (Bydureon), have been approved for use in the U.S. The main disadvantage of these GLP-1 analogs is they must be administered by subcutaneous injection.
* Another approach is to inhibit the enzyme that inactivates GLP-1 and GIP, DPP-4. Several DPP-4 inhibitors that can be taken orally as tablets have been developed.
* Once weekly dosage of GLP-1 receptor agonists is also an approved modality in treating type 2 diabetes.*

Anagrammer Crossword Solver is a powerful crossword puzzle resource site. We maintain millions of regularly updated crossword solutions, clues and answers of almost every popular crossword puzzle and word game out there. We encourage you to bookmark our puzzle solver as well as the other word solvers throughout our site. Explore deeper into our site and you will find many educational tools, flash cards and plenty more resources that will make you a much better player. Incretio: Incretins are a group of metabolic hormones that stimulate a decrease in blood glucose levels. Incre...